Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
Clinical trial NCT02176031 · COMPLETED
Trial details
- NCT number
- NCT02176031
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2019-02-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.